StockBraker Posted - 1 week ago

$MRTX 6 years and 4 months to go - For each Mirati share a shareholder owned, they received one CVR. The CVR entitles the shareholder to a potential $12 cash payment if the FDA accepts a new drug application for Mirati's MRTX1719 therapy within seven years of the acquisition. The total value of the CVRs is approximately $1 billion.

aleaiacta Posted - 1 month ago

@RallyRaider Wasn’t $MRTX sold for $5.8 B? $1.8 B will buy you a boatload of “ice cream”…

NVDAMillionaire Posted - 08/16/24

$MRTX Mirati Therapeutics, Inc. (NASDAQ:MRTX): A Promising Oncology Company Navigating the Complexities of Drug Development and Commercialization http://beyondspx.com/2024/08/05/mirati-therapeutics-inc-nasdaqmrtx-a-promising-oncology-company-navigating-the-complexities-of-drug-development-and-commercialization/

Quantumup Posted - 3 months ago

Jefferies🏁 $RVMD Buy/$63, says $RVMD could capture🔟's of $B opp in RAS-mutated cancers thru a pipeline of differentiated RAS (ON) inhibitors — $RVMD' RAS inhibitor can tackle 5X broader mkt vs $AMGN& $MRTX= $BMY's KRAS Therapies. Jefferies sees significant⬆️side on a🐈rich 2H:

nikoleb Posted - 3 months ago

$KRTX, $MRTX - Two of my Sell list stocks have been acquired by $BMY. I'm not sure of the significance of it.

joachim52 Posted - 06/15/24

$AUPH $MRTX Mirati‘s CEO left and the company was bought out within 8 weeks or so. Expect the same here with corrupt Peter G forced to leave the company!

Night_Owl_Biotech Posted - 05/30/24

History suggests $DAWN is a good candidate, again candidate, for acquisition. $NVS is a potential buyer. The attachment calculates a theoretical DAWN M&A valuation & fully diluted share price assuming: 1. FY27 & FY28 DAWN analyst consensus revenue estimates are accurate (sourced via Seeking Alpha & Fintel). We do not know why Seeking Alpha & Fintel report different FY28/29 revenue estimates which is why we calculate value using both...AND if; 2. DAWN is acquired at the median peer year 4 revenue multiple as calculated by Centerview Partners in their written fairness opinion on the $MRTX acquisition and/or a median peer year 5 revenue multiple as Lazard noted in their fairness opinion on the $IMGN acquisition. We are not qualified to offer an opinion on whether DAWN analyst revenue estimates are credible nor if Centerview or Lazard's peers are reasonable for DAWN. As always, our math could also be wrong. This is not investment advice.

ians Posted - 05/24/24

@sweddle Actually it does now. Cash per share is $5.42 Besides dilution is not bad since it will be used to expand the business by supporting product launch & pipeline. Or it could be a moot point if VSTM is BO. Look at how much $BMY paid for $MRTX. $4.8B🤑

Profitfire Posted - 05/22/24

@IwannaRetire I got often same Experience 🌚😂 $EXAS $MRTX $MDGL for Example I bought most of them on the all time lows then boom 💥 this thing should up above 6-8$ This year

macstock Posted - 5 months ago

$MRTX amazing how they can just hold your money for months and months without paying you out…

SM07 Posted - 04/26/24

@clownmarket Something similar happened to $MRTX, post $BMY acquisition. EU approval likely now and, if so, a takeout will follow suit.

Profitfire Posted - 04/16/24

$REVB since the CLOSED offering for 4.55$ we never reached the warrant zone!!! The shitshow must done soon here. With low volume price getting down no panic sells news flow still good, Earnings a good so sometimes is brewing behind the scenes… remember me to $MRTX $INBS pops there was the same game we will see near time what will happen 🌚

SwingBy Posted - 6 months ago

$MRTX Sorry guys. When am I going to get that $11 or $13 payment? What type of item is this going be listed on 1099-B?

SM07 Posted - 03/15/24

$APLS could easily be sold now at $80-90 to a European BP. No new financing required and Europe sorted (see $MRTX)

jonnj Posted - 7 months ago

$AUPH Starting to sound real like $MRTX. But without the drugs and patents and the bp buy out. https://www.espn.co.uk/football/story/_/id/39377666/tottenham-owner-joe-lewis-pleads-guilty-insider-trading-charges

LoneBroker Posted - 7 months ago

$MRTX yummy 😋

db4 Posted - 02/28/24

$MCRB Ha ha It reminds of $MRTX behavior back in 2016-2017 when stock plunged from $35 to $2-3 range, and i was accumulating shares for almost a year ; that was last time i invested in Biotech since i normally don’t . i sold MRTX around $50 and regret doing it because a few months later it hit $250 , and last year company got acquired at $ 50 i’ll try not to make a similar mistake MCRB is a pioneer in space/area which in my opinion has a bright future and with revolutionary product they have -Sky is the limit Good luck to you all here, don’t be afraid to hold

PitBullTrades Posted - 02/27/24

$GRTS AA talking big. Starting 5 Ph3's , that's not something you can say that easily. He's got proper confidence on data. Also partnering up, that's what we want to see. Get all those trials running and $ influx. MIRATI with it's KRAS drugs reached $10B mc, then got bought out by Myers having no drugs in market with lots of studies and partners going on. KRAS being our 2nd approach. Could pull a similar move as $MRTX. Turning point incoming 🎯

Quantumup Posted - 8 months ago

Piper Sandler🏁 $TNGX OW/$18 $TNGX' MTA-cooperative PRMT5 inhibitor portfolio is well positioned w/in precision oncology. PS sees initial clinical data from MRTX1719 and AMG 193 as establishing *unambiguous clinical PoC 4 class; sees TNG908/TNG462 as pot FiC/BiC opp. $BMY $MRTX $AMGN $IDYA

kuda8 Posted - 8 months ago

$MRTX got cash and cvr : good luck for mrtx1719

ElijahJobs Posted - 01/26/24

$MRTX Hey, assholes, where is my CRV? Pay me!!! Oh, when is the approval?

TheGunnerAB Posted - 01/26/24

$DAWN I'm seeing similar pre BO action here, just like I reported on $MRTX. It will be funny if this one gets sold out prior to $AUPH, just like MRTX was. I posted about MRTX getting BO prior to AUPH. Let's hope it happens again.

StockBraker Posted - 01/24/24

$MRTX Symbol is now closed. Expect your $58/share to show up in your account soon depending on your broker. CVR of $12 will not occur until all the requirements occur. Expiration date is January 23, 2031. https://www.sec.gov/ix?doc=/Archives/edgar/data/1576263/000114036124003287/n70019397x1_8k.htm

DoctrBenway Posted - 01/24/24

$MRTX Little late:

STCKPRO Posted - 01/24/24

$MRTX NEW ARTICLE : Scotiabank Reaffirms Their Hold Rating on Mirati Therapeutics (MRTX) https://stck.pro/news/MRTX/73665369/

Aigner_Andreas Posted - 01/24/24

TF SELL $MRTX at 41.75 : 57.8 MidCap 50% Shp 0.71 S 1.03 N 0.87 RSI 6.31% SRSI 0% ADXR 45.49 #stocks #trading #finance #market

jb02345 Posted - 01/23/24

$MRTX how do you get the CVR? Do i have to hold this for many years

DoctrBenway Posted - 01/23/24

$MRTX I would like my money, please. My CVR, too.

SwingBy Posted - 01/23/24

$MRTX Anybody knows when are they going to give that $11? I have been holding it for 3 years… wanna to get out w/ minim loss. Thank you.

risenhoover Posted - 01/23/24

$MRTX / Mirati Therapeutics files form S-8 POS https://fintel.io/doc/sec-mirati-therapeutics-inc-1576263-s8-pos-2024-january-23-19745-5369?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing